Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
2 studies found for:    18024866 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Terminated Pharmacogenetic Factors and Side Effects of Metoclopramide and Diphenhydramine
Condition: Drug Metabolism, Poor, CYP2D6-RELATED
Interventions: Drug: Diphenhydramine;   Drug: Metoclopramide
2 Not yet recruiting A Study to Evaluate Exemestane Tablets Combined With Ovarian Function Suppression/Ablation in Treatment of Premenopausal Breast Cancer Patients With CYP2D6*10 Mutations (STEP)
Condition: CYP2D6 Polymorphism
Interventions: Drug: Exemestane Tablets;   Other: ovarian function suppression/ablation;   Genetic: CYP2D6*10 gene test;   Drug: Tamoxifen

Study has passed its completion date and status has not been verified in more than two years.